7th November 2019

Triathlete receives sanction

The Australian Sports Anti-Doping Authority (ASADA) today acknowledged the decision of the Court of Arbitration for Sport (CAS) to impose a two year and nine month ban on athlete Christopher Goodrick for the possession of prohibited substances. Mr Goodrick breached Triathlon Australia’s anti-doping policy for the possession of the prohibited substances Clomiphene, Anastrozole and Testosterone.

Under category S1 of the World Anti-Doping Code Prohibited List 2014, Testosterone is prohibited both in-and out-of-competition. Under category S4 of the World Anti-Doping Code Prohibited List 2014, Clomiphene and Anastrozole are prohibited both in- and out-of-competition.

Anabolic agents pose many threats to an athlete’s health and some side effects may include an increase in blood pressure and cholesterol levels which can lead to heart disease. Liver disease and infertility can also result from the use of these agents.

Similar to other substances with anabolic properties that lead to increased muscle mass, clomiphene, an anti-estrogenic substance, is associated with a number of potential and serious side effects, including increased risk of negative cardiovascular events, liver damage, and gastrointestinal discomfort. Anastrozole, an aromatase inhibitor and a treatment for breast cancer, can cause a loss of strength and energy, joint pain, hot flushes, headaches, and nausea.

Mr Goodrick is ineligible to participate in any sports that have adopted a World Anti-Doping Code compliant anti-doping policy until 14 February 2020. He is also not permitted to compete in a non-Signatory professional league or Event organised by a non-Signatory International or National level event organisation.

• This media release was published by the Australian Sports Anti-Doping Authority (ASADA) on 7 November 2019. Click here for the original.

You may also like...

Pin It on Pinterest

Share This